|
SLMAP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.45470310744622E-13 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
6.820500E-02 |
| Stage1-vs-Stage3 |
2.857200E-01 |
| Stage1-vs-Stage4 |
2.238000E-03 |
| Stage2-vs-Stage3 |
3.002100E-02 |
| Stage2-vs-Stage4 |
1.302290E-03 |
| Stage3-vs-Stage4 |
9.928100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.79567513373058E-13 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
4.674200E-01 |
| Caucasian-vs-Asian |
4.900800E-01 |
| AfricanAmerican-vs-Asian |
2.409200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.543400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
3.591700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.409800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.294800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.849000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.851600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.406000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.453800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.267700E-02 |
| Classical-VS-Follicular |
9.262900E-03 |
| Classical-VS-Other |
2.317200E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
3.239600E-04 |
| Tall-VS-Other |
7.387400E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
5.760900E-03 |
| Follicular-VS-Normal |
1.64568358940187E-12 |
| Other-VS-Normal |
2.2269963650956E-11 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.572130E-02 |
|
|
